Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population

This cross-sectional study investigates the extent to which individuals meeting label criteria for novel weight loss medications may not have been included in pivotal trials.

Authors

Institutions

Publication Details

Journal
JAMA Internal Medicine
Published
2024-11-25
DOI
https://doi.org/10.1001/jamainternmed.2024.6340
Citations
3
Primary Topic
Pharmacology and Obesity Treatment
Type
article
Field-Weighted Citation Impact
1.34
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population

Lily G. Bessette, Timothy S. Anderson
3 citations
JAMA Internal Medicine
Pharmacology and Obesity Treatment
1.34
article

Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population

Lily G. Bessette, Timothy S. Anderson
article en
3 citations

Abstract

This cross-sectional study investigates the extent to which individuals meeting label criteria for novel weight loss medications may not have been included in pivotal trials.

JAMA Internal MedicineVol. 185(1)
University of Pittsburgh (US), VA Pittsburgh Healthcare System (US)
Openalex Percentile: Top 18%
Pharmacology and Obesity Treatment
1.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Generalizability of Clinical Trials of Novel Weight Loss Medications to the US Adult Population — Lily G. Bessette, Timothy S. Anderson · JAMA Internal Medicine (2024) | TGRS Research Map | TGRS